Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Altor in connection with the investment in H2 Green Steel (1)
Mandate

Vinge advises Altor in connection with the investment in H2 Green Steel

September 08, 2023 M&A Environmental Law Public Procurement Corporate Crime & Compliance Banking and Finance Real Estate and Construction Commercial Agreements EU, Competition and Regulatory Intellectual Property

Vinge represents Altor in connection with its investment in H2 Green Steel. The investment has been carried out in connection with 1.5 billion euro investment round in H2 Green Steel. Investors participating in the capital raise included, in addition to Altor, inter alia AMF, GIC, Hitachi Energy, Kinnevik, Schaeffler, Andra AP-fonden, FAM, Hy24 and Just Climate.

H2 Green Steel was founded in 2020 with the ambition to accelerate the decarbonization of hard-to-abate industries. The company is starting with steel, which is one of the world’s largest carbon dioxide emitters, building a plant in Boden, northern Sweden. The plant will produce green steel, reducing CO2 emissions with up to 95 percent compared to traditional steelmaking. Groundwork has been in progress at the Boden site since the summer of 2022, and with this transaction, H2 Green Steel is taking a significant step closer to commencing operations by the end of 2025.

Vinge's team consisted mainly of Johan Larsson, Isabelle Wållgren, Robin Fagerström (M&A), Christoffer Nordin, Jolene Reimerson, Elis Allmark (Commercial Agreements), Johan Cederblad, Lina Österberg (Environment), Kristoffer Larson (Real Estate), Mathilda Persson (IT), Mia Falk, Julia Löfqvist (Compliance), Louise Brorsson Salomon, Helena Göransson, Kamyar Najmi (Banking and Finance), Axel Lennartsson (IP), Johan Wahlbom (Competition law), Daniel Wendelsson (Regulatory), Emy Rydén and Ottilia Pettersson (project assistants).

 

Related

Vinge has advised Vitamin Well and its majority shareholders Cinven, Bridgepoint and the founders on Vitamin Well's combination with EMPWR

 Vinge has advised Vitamin Well and its majority shareholders Cinven, the founders of Vitamin Well and Bridgepoint on Vitamin Well's acquisition of EMPWR Nutrition Group from majority seller Waterland Private Equity Investments.
July 03, 2026

Vinge has advised Morrow Bank in connection with its issuances of primary capital instruments (AT1) and tier 2 capital bonds (T2)

 The issuances comprised perpetual AT1 bonds of NOK 300 million with a floating coupon of 3-month NIBOR + 425 basis points and a first call date in 2031, as well as subordinated Tier 2 bonds of SEK 200 million with a floating coupon of 3-month STIBOR + 325 basis points and a first call date in 2031. The bonds are intended to be admitted to trading on Nasdaq Stockholm.
July 03, 2026

Vinge advises Wihlborgs Fastigheter in connection with the financing of property acquisition valued at SEK 13.3 billion

 Vinge advises Wihlborgs Fastigheter AB (publ) in connection with the financing of the acquisition of all of Castellum’s property holdings in Malmö, Lund and Helsingborg. The financing has been secured through Danske Bank, SEB and Swedbank.
June 29, 2026